(RTTNews) - Sandoz has announced that WYOST and Jubbonti are available to patients in the US. WYOST and Jubbonti are the first and only interchangeable FDA-approved denosumab biosimilars and are appro ...

Sean Ho, Founder & CIO at Triata Capital, discusses why he sees further upside for PDD despite risks from US-China tensions. The US-listed Chinese e-commerce firm was Ho's investment pick at this year ...

Plug Power (NASDAQ: PLUG), a hydrogen fuel cell company, is experiencing significant financial challenges, leading to a 60% year-to-date stock price decline. Currently trading at just under $1, the st ...

(RTTNews) - Kura Oncology Inc. (KURA) and Kyowa Kirin Co., Ltd. announced the U.S. Food and Drug Administration has accepted Kuras New Drug Application or NDA seeking full approval for ziftomenib as a ...

(RTTNews) - Nxera Pharma Co., Ltd. announced that it has achieved a development milestone under its multi-target collaboration and license agreement with Eli Lilly and Co. (LLY) targeting diabetes and ...

(RTTNews) - The Puutu Kunti Kurrama and Pinikura (PKKP) Aboriginal Corporation and Rio Tinto have agreed to work together to build a strong and lasting partnership. This agreement sets clear rules on ...

CALGARY, Alberta, June 01, 2025 (GLOBE NEWSWIRE) -- Cenovus Energy Inc. (TSX: CVE) (NYSE: CVE) is providing an update on its Oil Sands operations following ongoing wildfire activity in northern Albert ...

Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any ...

Rodin Eckenroth/Getty Images Entertainment Disney’s (NYSE:DIS [https://seekingalpha.com/symbol/DIS]) live-action "Lilo & Stitch" continued its box-office dominance for the second straight weekend, pul ...

Below is Validea's guru fundamental report for INTERNATIONAL BUSINESS MACHINES CORP (IBM). Of the 22 guru strategies we follow, IBM rates highest using our Twin Momentum Investor model based on the pu ...

(RTTNews) - AstraZeneca PLC (AZN) announced positive results from the SERENA-6 Phase III trial, demonstrating that camizestrant, in combination with a cyclin-dependent kinase (CDK) 4/6 inhibitor, sign ...

Campbell’s and Hewlett Packard Enterprise will also report earnings, and Friday’s jobs report headlines the week’s economic data. Continue Reading View Comments ...